Related Experiment Video

Updated: Jun 6, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

The rising PET: the increasing use of choline PET/CT in prostate cancer

Arturo Chiti, Maria Picchio

    European Journal of Nuclear Medicine and Molecular Imaging
    |November 25, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
    11:43

    Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

    Published on: December 30, 2016

    Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring
    08:45

    Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring

    Published on: November 13, 2012

    Related Experiment Videos

    Last Updated: Jun 6, 2026

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
    06:54

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

    Published on: September 3, 2013

    Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
    11:43

    Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

    Published on: December 30, 2016

    Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring
    08:45

    Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring

    Published on: November 13, 2012

    Related Concept Videos

    Positron Emission Tomography01:29

    Positron Emission Tomography

    Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
    One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
    Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

    Imaging Studies II: Positron Emission Tomography and Scintigraphy

    Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
    Fundamental Principles of PET

    Articles linked to this work by shared authors, journal, and citation graph.

    PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study.

    European urology·2026

    [18F]FDG PET/MRI for axillary staging in node positive breast cancer patients receiving primary systemic therapy. A prospective single arm trial.

    Breast (Edinburgh, Scotland)·2026

    Diagnostic accuracy of modern imaging following neoadjuvant therapy for breast cancer: a comparative analysis of ultrasound versus [18F] FDG PET/MRI in breast response assessment.

    Frontiers in oncology·2026

    Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

    European urology·2026

    From Target Engagement to Treatment Governance: The Evolving Role of Amyloid PET in Anti-Amyloid Therapy.

    The Lancet regional health. Europe·2026

    First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493).

    Theranostics·2026

    Differentiation of axial spondyloarthritis-related lesions from degenerative lesions on Na[18F]Fluoride PET/CT in a longitudinal dataset of patients with radiographic axial spondyloarthritis.

    European journal of nuclear medicine and molecular imaging·2026

    ¹⁸F-sodium fluoride PET/CT as a complementary measure of osteoblastic disease burden in axial spondyloarthritis: a prospective exploratory study.

    European journal of nuclear medicine and molecular imaging·2026

    First-in-human dosimetry and biodistribution of [89Zr]Zr-oxine-labeled autologous leukocytes using PET/CT.

    European journal of nuclear medicine and molecular imaging·2026

    Diagnostic performance of multiparametric model integrating ¹⁸F-MFBG PET/CT imaging parameters and clinical factors for differentiating neuroblastoma from ganglioneuroblastoma: a preliminary study.

    European journal of nuclear medicine and molecular imaging·2026

    PD-L1 PET/CT imaging with 18F-BMS-986,229 and 18F-BMS-986,192 in patients with advanced-stage non-small cell lung cancer.

    European journal of nuclear medicine and molecular imaging·2026

    A FABulous approach to image human macrophages.

    European journal of nuclear medicine and molecular imaging·2026

    From Phase Ib/II to Seamless Phase II/III: A Simulation-Based Discussion of Design Strategies for Dose Optimization and Confirmatory Phase.

    Clinical pharmacology and therapeutics·2026

    INSR Armoring Protects CAR-NK and CAR-T Cells Against Tumor Stroma-Induced CAR Shedding by Maintaining Cholesterol Homeostasis.

    Cancer research·2026

    Matching-adjusted indirect treatment comparisons in chronic inflammatory demyelinating polyneuropathy: interpreting current evidence and enhancing future studies.

    Journal of comparative effectiveness research·2026

    Epidemiology of medication-related problems and antimicrobial utilisation among critically ill cancer patients: Determinants, pharmacist interventions and clinical outcomes-A prospective observational study.

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

    Enhancing Cancer Immunotherapy with Berberine and Its Loaded Nanoparticles: A Systematic Review.

    Anti-cancer agents in medicinal chemistry·2026

    Magnetic and Non-Magnetic Halloysite Nanotubes Functionalized with Folic Acid for the Targeted Delivery of [Pd(dipic)Cl].H2O: Cytotoxicity and Apoptosis Induction in Colon Cancer Cells.

    Anti-cancer agents in medicinal chemistry·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us